This list will be manually updated on a regular basis. The table below was last updated at 2:00 pm EST on March 21, 2013.
| Objective | Description | Volunteers |
|---|---|---|
| 1 | Coordinate with the Ontologies & Databases CoR on terminology and resources and enable inputs from the Ecotoxicology Testing & Predictive Models CoR, the Predictive Modeling for Human Health CoR, and the Exposure through the Life Cycle CoR to be meaningfully analyzed by methods from the Risk Assessment CoR in a manner that supports informed decision-making by the Risk Management & Control CoR. | Christine Hendren, Mark Hoover, Christy Powers, Derk Brouwer, Amy Wang |
| 2 | Inventory methods and tools available for assessing and comparing potential risks and changes in risk for engineered nanomaterials and nano-enabled products (including applications such as medical diagnostics and treatment). | Henrik Wolff, Khara Grieger, Alex Orlov, Derk Brouwer, Carsten Kneuer, Stefania Gottardo, Teresa Fernandes, Carlos Fito Lopez, Margriet Park, Stacey Harper, Andrea Haase, Amy Wang |
| 3 | Match tools with end-user mission and decision needs, including the use of appropriate risk definitions, life cycle , and risk and benefit assessment and management tools of appropriate computational complexity. | Igor Linkov, Khara Grieger, Alex Orlov, Derk Brouwer, Christy Powers, Stefania Gottardo, Carlos Fito Lopez, Stefano Pozzi Mucelli |
| 4 | Identify gaps among tools, data, stakeholder missions, and management need. | Khara Grieger, Igor Linkov, Henrik Wolff, Carsten Kneuer, Stefania Gottardo |
| 5 | Review data to assess underlying physicochemical parameters and environmental conditions that can be used as predictors of nanoparticle risks. | Christine Hendren, Mark Wiesner, Alexander Orlov, Carsten Kneuer, Carlos Fito Lopez, Liz Casman, Pedro Alvarez, Stacey Harper, Andrea Haase, Amy Wang |
| 6 | Compare risks associated with engineered nanoparticles with those presented by materials from traditional manufacturing methods and with incidental and naturally occurring nanomaterials and evaluate associated uncertainty. | Mark Wiesner, Teresa Fernandes, Pedro Alvarez, Margriet Park, Jo Anne Shatkin, Stacey Harper, Andrea Haase, Amy Wang |
| 7 | Recommend a framework for including considerations of health and environmental impacts in planning and decision-making for the production, use, and disposal/recycling of nanomaterials and nano-enabled products. | Jo Anne Shatkin, Khara Grieger, Teresa Fernandes, Stacey Harper, Stefano Pozzi Mucelli, Amy Wang, Tom Theis |
| 8 | Recommend methods for calculating risks that allow for the ability to assess associated uncertainty as well as adapt and update risk estimates as new information becomes available or as stakeholder mission and decision needs change. | Khara Grieger, Teresa Fernandes, Carlos Fito Lopez, Margriet Park |
| 9 | Identify steps forward required to produce comparable risk calculations within a defined context or mission. | Liz Casman |
Discussion (0)
There are no comments for this doc yet.
Comment posting has been disabled on this doc.